<h2 class="mt-4 text-lg font-medium text-color-lightgreytext" data-astro-cid-fjd3bvuv>
Summary from the AllSides News Team
</h2> <div class="mt-2 text-md editor-content" data-astro-cid-fjd3bvuv><p>American drugmaker Merck announced Friday that it will seek emergency authorization of an experimental antiviral pill known as&nbsp;molnupiravir after it&nbsp;significantly reduced the worst effects of COVID-19 in clinical trials. The company said that in the trials, the&nbsp;treatment cut the risk of hospitalization or death in half when given to high-risk patients&nbsp;within the first five days of COVID-19 symptoms.&nbsp;By inserting errors into the virus' genetic code,&nbsp;the drug can reportedly minimize&nbsp;the duration of illness, mitigate serious symptoms and <a href="https://www.foxbusiness.com/lifestyle/merck-covid-19-antiviral-pill-effective-variants" target="_blank" rel="noopener noreferrer">"limit transmission to people in your household if you are sick."</a>&nbsp;Some experts&nbsp;are <a href="https://www.axios.com/merck-ridgeback-oral-antiviral-drug-coronavirus-e606bd4b-8505-40d9-b34b-a52af9e9a993.html" target="_blank" rel="noopener noreferrer">"optimistic that molnupiravir can become an important medicine as part of the global effort to fight the pandemic"</a>&nbsp;if authorized, alleviating&nbsp;pressure on hospitals and curbing infections in poorer areas across the globe. Merck said it expects to complete the third phase of trials by early November.&nbsp;Two other antiviral pills are being developed: one by Pfizer, and the other by Atea Pharmaceuticals and Roche. Both are expected to release their trial results in the coming months.</p>

<p>Coverage was prominent across the spectrum, with most outlets highlighting hopeful barometers&nbsp;that molnupiravir could play a key role&nbsp;in ending the COVID-19 pandemic.&nbsp;Some outlets also emphasized how White House COVID-19 Coordinator Jeff Zients said the antiviral pill could be an “additional tool in our toolbox” but that vaccinations remain the strongest tool.&nbsp;</p>
</div> <h2 class="mb-2 leading-6 text-lg text-gray-500 font-medium mt-4 p-0">
Featured Coverage of this Story
</h2> <div class="flex gap-5 my-2 mb-8 md:flex-row flex-col"> <div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--merck-s-promising-experimental-covid-19-drug-raises-hopes-for-pill-to-fight-virus" href="https://www.politico.com/news/2021/10/01/merck-covid-drug-514888" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">Merck&#39;s promising experimental Covid-19 drug raises hopes for pill to fight virus</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Politico</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-left.png" alt="AllSides Media Bias Rating: Lean Left" title="AllSides Media Bias Rating: Lean Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/download_286.jpeg" alt="Merck's promising experimental Covid-19 drug raises hopes for pill to fight virus" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Seth Wenig, File/AP Photo</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>News that an experimental antiviral drug from Merck appears to halve the risk of hospitalization or death from Covid-19 has bolstered hopes of finding a simple at-home treatment for the virus.</p><p>The drug, molnupiravir, is given as a pill. It performed well enough in a late-stage clinical trial of adults at high risk of severe Covid-19 that the independent review board overseeing the study recommended that it be ended early. Now Merck and its partner Ridgeback Biotherapeutics will seek FDA authorization for the drug “as soon as possible,” they said...</div><a id="Open-On--politico" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.politico.com/news/2021/10/01/merck-covid-drug-514888" target="_blank" rel="noopener">
Open on Politico<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div><script type="84e6e429a02e9cb2088dc6a3-module" src="/_astro/story-related-news.astro_astro_type_script_index_0_lang.DjPUAy8u.js"></script><div class="flex-1 right"><div class="mb-2 font-bold border-solid global-bias-label text-color-right border-b-[3px] text-s border-color-right">From the Right</div><a id="News-Item--merck-sees-promising-results-in-trial-of-covid-19-pill-will-apply-for-emergency-approval-from-fda" href="https://www.washingtontimes.com/news/2021/oct/1/merck-says-experimental-pill-cuts-worst-effects-of/" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">Merck sees promising results in trial of COVID-19 pill, will apply for emergency approval from FDA</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Washington Times</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-right.png" alt="AllSides Media Bias Rating: Lean Right" title="AllSides Media Bias Rating: Lean Right" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/Virus_Outbreak_Treatment_Merck_15750.jpg-00860_c0-114-2736-1709_s885x516.jpg" alt="Merck sees promising results in trial of COVID-19 pill, will apply for emergency approval from FDA" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Merck &amp; Co. via AP</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>Merck&nbsp;on Friday said it will seek emergency approval of an antiviral pill to treat COVID-19 after it significantly cut the risk of bad outcomes in clinical trials.</p><p>The New Jersey-based drugmaker said the drug, molnupiravir, cut the risk of hospitalization or death in half in high-risk patients with mild to moderate illness.</p><p>If authorized for use, it would be a groundbreaking treatment. Pills are easy to take and can reach a wider audience than monoclonal antibodies, an effective treatment in high demand.</p><p>Merck&nbsp;said it stopped the trial early in consultation...</div><a id="Open-On--washington-times" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.washingtontimes.com/news/2021/oct/1/merck-says-experimental-pill-cuts-worst-effects-of/" target="_blank" rel="noopener">
Open on Washington Times<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a><div class="flex-1 whitespace-nowrap text-gray-500 text-xs leading-4 flex mt-2"><div class="hover:cursor-help" data-tippy-content="<p><span style=&#34;white-space: nowrap;&#34;>Some content from this outlet may be</span><br><span style=&#34;white-space: nowrap;&#34;>limited or behind a paywall.</span></p>"><i class="fa-regular fa-sack-dollar mr-1"></i><span class="whitespace-nowrap">Possible Paywall</span></div></div></div></div><div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--merck-says-experimental-pill-cuts-worst-effects-of-covid-19" href="https://apnews.com/article/merck-says-experimental-covid-pill-cuts-worst-effects-a9a2245fdcee324f6bbd776a0fffcc60" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">Merck says experimental pill cuts worst effects of COVID-19</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Associated Press</p></div><img src="https://img.allsides.com/sites/default/files/bias-left.png" alt="AllSides Media Bias Rating: Left" title="AllSides Media Bias Rating: Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/1000_132.jpeg" alt="Merck says experimental pill cuts worst effects of COVID-19" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Merck &amp; Co. via AP</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, potentially a leap forward in the&nbsp;global fight against the pandemic.</p><p>The company said it will soon ask health officials in the U.S. and around the world to authorize the pill’s use. A decision from the U.S. Food and Drug Administration could come within weeks after that, and the drug, if OK’d, could be distributed quickly soon afterward.</p><p>If cleared, it would be the first pill shown to treat...</div><a id="Open-On--associated-press" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://apnews.com/article/merck-says-experimental-covid-pill-cuts-worst-effects-a9a2245fdcee324f6bbd776a0fffcc60" target="_blank" rel="noopener">
Open on Associated Press<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div> </div> <p class="mt-2 mb-5 text-right"> <a id="More-headline-roundups" class="group relative pr-5 hover:no-underline border-b border-opacity-0 hover:border-opacity-100 border-color-text inline-block w-fit cursor-pointer text-sm no-underline" href="/headline-roundups">